SCHEMBL25973085

SCHEMBL25973085

Cc1ccc([C@](C)(O)C2CCCN2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.53
NPC1 O15118 2/20 0.53
CYP1A2 P05177 2/20 0.53
HPGD P15428 2/20 0.53
CYP2C19 P33261 2/20 0.53
KDM4E B2RXH2 1/20 0.53
CYP2D6 P10635 1/20 0.53
MAPK1 P28482 1/20 0.53
TSHR P16473 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CHRM2 P08172 3/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
HRH1 P35367 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20832974 1.00 RAB9A (0.53) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL22260353 1.00 RAB9A (0.53) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL20833288 1.00 RAB9A (0.53) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL22260110 0.88 HPGD (0.54) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL19841237 0.86 CYP2D6 (0.70) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL14227426 0.86 CYP2D6 (0.70) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL3088977 0.86 CYP2D6 (0.70) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL16640675 0.86 CYP2D6 (0.70) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL20833321 0.86 CYP2D6 (0.70) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL16931709 0.86 CYP2D6 (0.70) RAB9ANPC1CYP1A2HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718638-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT RAB9A 3746/4885NPC1 3712/4885CYP1A2 4059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.